These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 31647157)

  • 21. Efficacy of the traditional Chinese medicine, Buyang Huanwu Decoction, at preventing taxane-induced peripheral neuropathy in breast cancer patients: A prospective, randomized, controlled study.
    Luo F; Wan D; Liu J; Chen D; Yuan M; Zhang C; Liu Q
    Medicine (Baltimore); 2024 Mar; 103(9):e37338. PubMed ID: 38428887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials.
    Vahdat LT; Thomas ES; Roché HH; Hortobagyi GN; Sparano JA; Yelle L; Fornier MN; Martín M; Bunnell CA; Mukhopadhyay P; Peck RA; Perez EA
    Support Care Cancer; 2012 Nov; 20(11):2661-8. PubMed ID: 22382588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Taxane-Induced Peripheral Neuropathy: Objective and Subjective Comparison Between Paclitaxel and Docetaxel in Patients With Breast Cancer.
    Chan YN; Jheng YW; Wang PJ; Chen CY; Lin MW; Wang YJ
    Clin J Oncol Nurs; 2019 Oct; 23(5):494-501. PubMed ID: 31538967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Taxane-induced peripheral neuropathy: differences in patient report and objective assessment.
    Timmins HC; Li T; Kiernan MC; Baron-Hay S; Marx G; Boyle F; Goldstein D; Park SB
    Support Care Cancer; 2020 Sep; 28(9):4459-4466. PubMed ID: 31925531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Taxane-induced neurotoxicity: Pathophysiology and therapeutic perspectives.
    da Costa R; Passos GF; Quintão NLM; Fernandes ES; Maia JRLCB; Campos MM; Calixto JB
    Br J Pharmacol; 2020 Jul; 177(14):3127-3146. PubMed ID: 32352155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetics of taxane-induced neurotoxicity in breast cancer: Systematic review and meta-analysis.
    Guijosa A; Freyria A; Espinosa-Fernandez JR; Estrada-Mena FJ; Armenta-Quiroga AS; Ortega-Treviño MF; Catalán R; Antonio-Aguirre B; Villarreal-Garza C; Perez-Ortiz AC
    Clin Transl Sci; 2022 Oct; 15(10):2403-2436. PubMed ID: 35892315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vinca alkaloids, thalidomide and eribulin-induced peripheral neurotoxicity: From pathogenesis to treatment.
    Islam B; Lustberg M; Staff NP; Kolb N; Alberti P; Argyriou AA
    J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S63-S73. PubMed ID: 31647152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current methods for the assessment and management of taxane-related neuropathy.
    Smith EM
    Clin J Oncol Nurs; 2013 Feb; 17 Suppl():22-34. PubMed ID: 23360700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of peripheral neuropathy associated with chemotherapy in four oncology centers of Colombia.
    Martinez JW; Sanchez-Naranjo JC; Londono-De Los Rios PA; Isaza-Mejia CA; Sosa-Urrea JD; Martinez-Munoz MA; Lopez-Osorio JJ; Marin-Medina DS; Machado-Duque ME; Machado-Alba JE
    Rev Neurol; 2019 Aug; 69(3):94-98. PubMed ID: 31309998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199.
    Schneider BP; Li L; Radovich M; Shen F; Miller KD; Flockhart DA; Jiang G; Vance G; Gardner L; Vatta M; Bai S; Lai D; Koller D; Zhao F; O'Neill A; Smith ML; Railey E; White C; Partridge A; Sparano J; Davidson NE; Foroud T; Sledge GW
    Clin Cancer Res; 2015 Nov; 21(22):5082-5091. PubMed ID: 26138065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
    Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K
    JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells.
    Giannakakou P; Gussio R; Nogales E; Downing KH; Zaharevitz D; Bollbuck B; Poy G; Sackett D; Nicolaou KC; Fojo T
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2904-9. PubMed ID: 10688884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taxane-induced neuropathy: How serious is this problem for patients with early breast cancer?
    Nicolae R; Uccellini A; Siderov J; Mellerick A; Wong V; Yeo B
    Asia Pac J Clin Oncol; 2023 Apr; 19(2):e118-e127. PubMed ID: 35692105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci.
    Sucheston-Campbell LE; Clay-Gilmour AI; Barlow WE; Budd GT; Stram DO; Haiman CA; Sheng X; Yan L; Zirpoli G; Yao S; Jiang C; Owzar K; Hershman D; Albain KS; Hayes DF; Moore HC; Hobday TJ; Stewart JA; Rizvi A; Isaacs C; Salim M; Gralow JR; Hortobagyi GN; Livingston RB; Kroetz DL; Ambrosone CB
    Pharmacogenet Genomics; 2018 Feb; 28(2):49-55. PubMed ID: 29278617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological and phenotypic profiles of taxane-induced neuropathy.
    Timmins HC; Li T; Huynh W; Kiernan MC; Baron-Hay S; Boyle F; Goldstein D; Park SB
    Clin Neurophysiol; 2020 Aug; 131(8):1979-1985. PubMed ID: 32291143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Identification of biomarkers and new therapies for taxane-induced peripheral neuropathy].
    Koyanagi M; Imai S; Nakagawa T; Matsubara K
    Nihon Yakurigaku Zasshi; 2019; 154(5):241-244. PubMed ID: 31735751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy and safety of ixabepilone (BMS-247550), a novel epothilone B analogue].
    Villanueva C; Dufresne A; Pivot X; Viel E
    Bull Cancer; 2008 Feb; 95(2):197-204. PubMed ID: 18304905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotoxicity of taxanes: symptoms and quality of life assessment.
    Kuroi K; Shimozuma K
    Breast Cancer; 2004; 11(1):92-9. PubMed ID: 14718800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Taxane-induced peripheral neuropathy and quality of life in breast cancer patients.
    Salehifar E; Janbabaei G; Alipour A; Tabrizi N; Avan R
    J Oncol Pharm Pract; 2020 Sep; 26(6):1421-1428. PubMed ID: 31937190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapy-induced peripheral neurotoxicity.
    Cavaletti G; Marmiroli P
    Expert Opin Drug Saf; 2004 Nov; 3(6):535-46. PubMed ID: 15500413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.